These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19430207)
21. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma. Holzmüller R; Mantwill K; Haczek C; Rognoni E; Anton M; Kasajima A; Weichert W; Treue D; Lage H; Schuster T; Schlegel J; Gänsbacher B; Holm PS Int J Cancer; 2011 Sep; 129(5):1265-76. PubMed ID: 21710499 [TBL] [Abstract][Full Text] [Related]
22. Oncolytic adenoviruses for the treatment of brain tumors. Gomez-Manzano C; Fueyo J Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384 [TBL] [Abstract][Full Text] [Related]
23. Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents. González-Pastor R; Ashshi AM; El-Shemi AG; Dmitriev IP; Kashentseva EA; Lu ZH; Goedegebuure SP; Podhajcer OL; Curiel DT J Ovarian Res; 2019 Feb; 12(1):18. PubMed ID: 30767772 [TBL] [Abstract][Full Text] [Related]
24. N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy. Kim CK; Ahmed AU; Auffinger B; Ulasov IV; Tobias AL; Moon KS; Lesniak MS Mol Ther; 2013 Nov; 21(11):2063-73. PubMed ID: 23883863 [TBL] [Abstract][Full Text] [Related]
25. The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Voss V; Senft C; Lang V; Ronellenfitsch MW; Steinbach JP; Seifert V; Kögel D Mol Cancer Res; 2010 Jul; 8(7):1002-16. PubMed ID: 20587533 [TBL] [Abstract][Full Text] [Related]
26. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of autophagy enhances the effects of E1A-defective oncolytic adenovirus dl922-947 against glioma cells in vitro and in vivo. Botta G; Passaro C; Libertini S; Abagnale A; Barbato S; Maione AS; Hallden G; Beguinot F; Formisano P; Portella G Hum Gene Ther; 2012 Jun; 23(6):623-34. PubMed ID: 22475378 [TBL] [Abstract][Full Text] [Related]
28. Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma. Milano V; Piao Y; LaFortune T; de Groot J Mol Cancer Ther; 2009 Feb; 8(2):394-406. PubMed ID: 19190119 [TBL] [Abstract][Full Text] [Related]
29. Conditionally replicating oncolytic adenoviral vector expressing arresten and tumor necrosis factor-related apoptosis-inducing ligand experimentally suppresses lung carcinoma progression. Li S; Qi Z; Li H; Hu J; Wang D; Wang X; Feng Z Mol Med Rep; 2015 Aug; 12(2):2068-74. PubMed ID: 25891208 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro. Gao S; Yang XJ; Zhang WG; Ji YW; Pan Q Chin Med J (Engl); 2009 Jun; 122(11):1260-6. PubMed ID: 19567134 [TBL] [Abstract][Full Text] [Related]
31. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1. Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275 [TBL] [Abstract][Full Text] [Related]
34. Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas. Jiang H; Gomez-Manzano C; Lang FF; Alemany R; Fueyo J Curr Gene Ther; 2009 Oct; 9(5):422-7. PubMed ID: 19860656 [TBL] [Abstract][Full Text] [Related]
35. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. Jiang G; Liu YQ; Wei ZP; Pei DS; Mao LJ; Zheng JN Cancer Lett; 2010 Aug; 294(2):220-8. PubMed ID: 20189296 [TBL] [Abstract][Full Text] [Related]
36. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma. Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma. Lamfers ML; Idema S; Bosscher L; Heukelom S; Moeniralm S; van der Meulen-Muileman IH; Overmeer RM; van der Valk P; van Beusechem VW; Gerritsen WR; Vandertop WP; Dirven CM Clin Cancer Res; 2007 Dec; 13(24):7451-8. PubMed ID: 18094429 [TBL] [Abstract][Full Text] [Related]
38. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models. Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142 [TBL] [Abstract][Full Text] [Related]
39. Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma. Geoerger B; Vassal G; Opolon P; Dirven CM; Morizet J; Laudani L; Grill J; Giaccone G; Vandertop WP; Gerritsen WR; van Beusechem VW Cancer Res; 2004 Aug; 64(16):5753-9. PubMed ID: 15313916 [TBL] [Abstract][Full Text] [Related]